Management of Supraventricular Tachycardia of Children

NCT03528616 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-05-18

No results posted yet for this study

Summary

• Supraventricular tachycardia (SVT) is defined as an abnormally rapid heart rhythm originating above the ventricles. It usually has narrow complex tachycardia but this is not always the case. Conventionally, atrial flutter and fibrillation are excluded from this group.ventricular tachycardia is the most common rhythm disturbance seen in children.(2) Most general practitioners will deal with a case at some point. While in most cases ventricular tachycardia can be considered a benign rhythm disorder, special consideration needs to be given to infants, athletes and patients with Wolff-Parkinson-White syndrome.

Conditions

  • Supraventricular Tachycardia

Interventions

DRUG

adenosine,Propranolol,flecainide, amiodarone, propranolol, digoxin and procainamide.

drugs used for treatment of supraventricular tachycardia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2019-04-30
Completion
2019-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03528616 on ClinicalTrials.gov